Aerie Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €166.20M +133.5% -€64.04M -59.1% -38.5% +1.8 pp -€82.07M +55.6% -49.4% +0.25 pp
    €71.17M +19.0% -€156.75M -8.3% -220.2% +0.65 pp -€52.73M -56.2% -74.1% +1.3 pp
    €59.83M +189.0% -€170.86M -14.2% -285.6% +6.8 pp -€120.26M +15.8% -201.0% +3.0 pp
    €20.70M +∞% -€199.10M +60.3% -961.8% -9.6 pp -€103.81M +57.0% -501.5% -5.0 pp
    €0.00 +NaN% -€124.22M +46.5% N/A -€66.13M +3.3% N/A
    €0.00 +NaN% -€84.80M +33.2% N/A -€64.00M +42.5% N/A
    €0.00 +NaN% -€63.66M +54.5% N/A -€44.92M +56.4% N/A
    €0.00 +NaN% -€41.21M +54.5% N/A -€28.72M +104.7% N/A
    €0.00 +NaN% -€26.67M +108.0% N/A -€14.03M +9.8% N/A
    €0.00 +NaN% -€12.82M +15.5% N/A -€12.77M +24.8% N/A
    €0.00 -€11.10M N/A -€10.23M N/A

    Notifications